Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Stage and grade distribution of bladder cancer in our study patients

From: ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

Patients groups and subgroupsa Ib(n = 43) II (n = 6)
  IA (n = 29)/IB (n = 14)  
  Number of cases per group  
Stage   
Ta 18 (41.9%) -
  14 (48.3%)/4 (28.5%)  
T1 25 (58.1%) -
  15 (51.7%)/10 (71.4%)  
T2 - 6 (100%)
Stage/grade   
TaG1c 12 (27.9%) -
  9 (31.0%)/4 (28.5%)  
TaG2 6 (13.9%) -
  5 (17.2%)/-(0%)  
T1G1 6 (13.9%)  
  5 (17.2%)/1 (7.1%)  
T1G2 14 (32.6%)  
  7 (24.1%)/7 (50.0%)  
T1G3 5 (11.6%)  
  3 (10.3%)/2 (14.3%)  
T2G2 - 3 (50%)
T2G3 - 3 (50%)
  1. aThe control group III used in this study was omitted from the table since it does not includes malignant tumors.
  2. bThe group II of patients were all treated by TURBT followed by the same dose and schedule of BCG instillations (TICE® BCG).
  3. cPatients with low risk, primary TaG1 cancers were not included in the study.